Literature DB >> 14967153

Haptoglobin polymorphism in breast cancer patients form Jordan.

Samir M Awadallah1, Manar F Atoum.   

Abstract

BACKGROUND: Previous reports regarding the occurrence of breast cancer and its association with Hp polymorphism are conflicting. The possible role of family history as a factor in determining the degree of association between the disease and Hp polymorphism has not been reported before. In this study, the distribution of haptoglobin phenotype among patients with familial and nonfamilial breast cancer was investigated.
METHODS: Haptoglobin phenotypes were determined in serum of 128 breast cancer patients (familial, n=42; nonfamilial, n=86) and in controls (n=200) by vertical polyacrylamide gel electrophoresis.
RESULTS: No significant difference of Hp phenotype distribution was observed between patients as a combined group when compared with the control group. In the familial group, the frequency of Hp1-1 and Hp2-1 phenotype distribution was higher and Hp2-2 was lower than that in the nonfamilial and the control groups. Similar but inversed Hp distribution pattern was observed in the nonfamilial group when compared with that in the other groups. An appreciable finding is the observation that Hp2-2 phenotype frequency in the nonfamilial group was significantly higher than that in the familial group (p=0.0365).
CONCLUSIONS: Results of this study demonstrate that the pattern of Hp phenotype distribution in breast cancer patients is family history-dependent. Hp1 and Hp2 allele frequencies were over-represented in patients with familial and nonfamilial breast cancer, respectively. The pattern is probably attributed to genetic and oxidative stress mechanisms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14967153     DOI: 10.1016/j.cccn.2003.10.032

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  12 in total

1.  Haptoglobin is a serological biomarker for adenocarcinoma lung cancer by using the ProteomeLab PF2D combined with mass spectrometry.

Authors:  You-Kang Chang; Yu-Heng Lai; Yen Chu; Ming-Cheng Lee; Chun-Yao Huang; Semon Wu
Journal:  Am J Cancer Res       Date:  2016-08-01       Impact factor: 6.166

2.  Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer.

Authors:  Changqing Zhao; Loganath Annamalai; Changfa Guo; Narasimhan Kothandaraman; Stephen Chee Liang Koh; Huoming Zhang; Arijit Biswas; Mahesh Choolani
Journal:  Neoplasia       Date:  2007-01       Impact factor: 5.715

3.  Multiple biomarker algorithms to predict epithelial ovarian cancer in women with a pelvic mass: Can additional makers improve performance?

Authors:  Richard G Moore; Alexandra Blackman; M Craig Miller; Katina Robison; Paul A DiSilvestro; Elizabeth E Eklund; Robert Strongin; Geralyn Messerlian
Journal:  Gynecol Oncol       Date:  2019-04-13       Impact factor: 5.482

4.  Potential biomarkers in the sera of breast cancer patients from bahawalpur, pakistan.

Authors:  Faiz-Ul-Hassan Nasim; Samina Ejaz; Muhammad Ashraf; Abdul Rehman Asif; Michael Oellerich; Gulzar Ahmad; Gulzar Ahmad Malik
Journal:  Biomark Cancer       Date:  2012-12-10

5.  Potential markers for detection and monitoring of ovarian cancer.

Authors:  Brandon J D Rein; Sajal Gupta; Rima Dada; Joelle Safi; Chad Michener; Ashok Agarwal
Journal:  J Oncol       Date:  2011-04-11       Impact factor: 4.375

6.  Decreased serum level of thioredoxin 1 in female patients with pneumonia and its combinational use with haptoglobin for the specific diagnoses of pneumonia and lung cancer.

Authors:  Mee-Kyung Cha; Il-Han Kim
Journal:  Pneumonia (Nathan)       Date:  2015-12-01

7.  Trans-ethnic predicted expression genome-wide association analysis identifies a gene for estrogen receptor-negative breast cancer.

Authors:  Guimin Gao; Brandon L Pierce; Olufunmilayo I Olopade; Hae Kyung Im; Dezheng Huo
Journal:  PLoS Genet       Date:  2017-09-28       Impact factor: 5.917

8.  Proteomic identification of fucosylated haptoglobin alpha isoforms in ascitic fluids and its localization in ovarian carcinoma tissues from Mexican patients.

Authors:  Olga Lilia Garibay-Cerdenares; Verónica Ivonne Hernández-Ramírez; Juan Carlos Osorio-Trujillo; Magdalena Hernández-Ortíz; Dolores Gallardo-Rincón; David Cantú de León; Sergio Encarnación-Guevara; Julio César Villegas-Pineda; Patricia Talamás-Rohana
Journal:  J Ovarian Res       Date:  2014-02-27       Impact factor: 4.234

9.  A panel of tumor markers, calreticulin, annexin A2, and annexin A3 in upper tract urothelial carcinoma identified by proteomic and immunological analysis.

Authors:  Chih-Ming Lu; Jen-Jie Lin; Han-Hsiang Huang; Ying-Chin Ko; Jue-Liang Hsu; Jiing-Chuan Chen; Zhong-Hao Din; Yu-Jen Wu
Journal:  BMC Cancer       Date:  2014-05-23       Impact factor: 4.430

10.  Haptoglobin and CCR2 receptor expression in ovarian cancer cells that were exposed to ascitic fluid: exploring a new role of haptoglobin in the tumoral microenvironment.

Authors:  O L Garibay-Cerdenares; V I Hernández-Ramírez; J C Osorio-Trujillo; D Gallardo-Rincón; P Talamás-Rohana
Journal:  Cell Adh Migr       Date:  2015-07-25       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.